|
ANIX | Anixa Biosciences Inc |
|
|
ANIX | Anixa Biosciences Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.12 |
| Leverage | 12.69% |
| Market Cap | $ 128.7m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -11.1m |
| Margin | -21247.01% |
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is headquartered in San Jose, California.